Unknown

Dataset Information

Treatment of Anemia With Darbepoetin Prior to Dialysis Initiation and Clinical Outcomes: Analyses From the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).


ABSTRACT:

Rationale & objective

Evidence from clinical trials to guide patient preparation for maintenance dialysis therapy is limited. Although anemia is associated with mortality and cardiovascular (CV) disease in individuals initiating maintenance dialysis therapy, it is not known if treatment of anemia before dialysis therapy initiation with erythropoiesis-stimulating agents alters outcomes.

Study design

Post hoc analysis of a randomized controlled trial.

Setting & participants

Participants with type 2 diabetes and chronic kidney disease who progressed to dialysis therapy (n=590) in the Trial to Reduce Cardiovascular Events With Aranesp Therapy (TREAT).

Exposure

Randomized treatment assignment (darbepoetin vs placebo).

Outcomes

All-cause mortality, CV mortalit

SUBMITTER: Mc Causland FR 

PROVIDER: S-EPMC6420804 | biostudies-literature | 2019 Mar

REPOSITORIES: biostudies-literature